GMNN and breast cancer: To determine whether geminin overexpression also maintains breast tumor growth in vivo, the very aggressive breast cancer cell line, MDAMB231 [29, 30] that endogenously overexpress geminin (see Figure 7A) was used to generate clones that express 3 different conditional geminin shRNAs or a GFP shRNA (as control).